Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm
Open Access
- 11 September 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 73 (10), 1219-1236
- https://doi.org/10.1007/s00228-017-2301-8
Abstract
No abstract availableKeywords
Funding Information
- This project was supported by the Dutch Top Institute Pharma (TI Pharma).
This publication has 107 references indexed in Scilit:
- Cardiovascular Disease: The Other Face of DiabetesCPT: Pharmacometrics & Systems Pharmacology, 2013
- A brief comparison of the pathophysiology of inflammatory versus neuropathic painCurrent Opinion in Anaesthesiology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- The discovery and development of analgesics: new mechanisms, new modalitiesJCI Insight, 2010
- Cortical disinhibition occurs in chronic neuropathic, but not in chronic nociceptive painBMC Neuroscience, 2010
- fMR-adaptation indicates selectivity to audiovisual content congruency in distributed clusters in human superior temporal cortexBMC Neuroscience, 2010
- Assessing efficacy of non‐opioid analgesics in experimental pain models in healthy volunteers: an updated reviewBritish Journal of Clinical Pharmacology, 2009
- Neuropathic Pain: A Maladaptive Response of the Nervous System to DamageAnnual Review of Neuroscience, 2009
- The biochemical origin of pain – Proposing a new law of pain: The origin of all pain is inflammation and the inflammatory response. Part 1 of 3 – A unifying law of painMedical Hypotheses, 2007
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001